275 related articles for article (PubMed ID: 21948647)
1. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.
Berner D; Zenkel M; Pasutto F; Hoja U; Liravi P; Gusek-Schneider GC; Kruse FE; Schödel J; Reis A; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5930-5940. PubMed ID: 29164236
[TBL] [Abstract][Full Text] [Related]
4. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.
Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U
Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533
[TBL] [Abstract][Full Text] [Related]
6. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
7. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
9. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
[TBL] [Abstract][Full Text] [Related]
10. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
11. Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates.
Zadravec P; Braunger BM; Melzer B; Kroeber M; Bösl MR; Jägle H; Schlötzer-Schrehardt U; Tamm ER
Exp Eye Res; 2019 Feb; 179():115-124. PubMed ID: 30399364
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Profiles of LOXL-1, FBN1, TGF-β1, and COX-2 in Pseudoexfoliation Syndrome.
Papadopoulou M; Papadaki H; Zolota V; Gartaganis SP
Curr Eye Res; 2017 Jun; 42(6):880-889. PubMed ID: 28085506
[TBL] [Abstract][Full Text] [Related]
13. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation.
Gayathri R; Coral K; Sharmila F; Sripriya S; Sripriya K; Manish P; Shantha B; Ronnie G; Vijaya L; Narayanasamy A
Curr Eye Res; 2016 Oct; 41(10):1331-1338. PubMed ID: 27116380
[TBL] [Abstract][Full Text] [Related]
16. Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma.
Zenkel M; Kruse FE; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5558-66. PubMed ID: 18055805
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3.
Tong J; Fu Y; Xu X; Fan S; Sun H; Liang Y; Xu K; Yuan Z; Ge Y
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2747-56. PubMed ID: 24667864
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression in pseudoexfoliation syndrome.
Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
[TBL] [Abstract][Full Text] [Related]
19. Analysis of LOXL1 single nucleotide polymorphisms in Polish population with pseudoexfoliation syndrome.
Malukiewicz G; Lesiewska-Junk H; Linkowska K; Mielnik M; Grzybowski T; Sulima N
Acta Ophthalmol; 2011 Feb; 89(1):e64-6. PubMed ID: 21272281
[TBL] [Abstract][Full Text] [Related]
20. LOXL1 Hypermethylation in Pseudoexfoliation Syndrome in the Uighur Population.
Ye H; Jiang Y; Jing Q; Li D; Maimaiti T; Kasimu D; Lu Y
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5838-43. PubMed ID: 26348632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
